Neumedicines Inc entered the industry of Medical Research in 2002 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 5417114, which describes it as a Medical Research. For further clarification, the SIC classifies this business under the code 8733 and described it as a Medical Research. The business provides service to the B2B market.
To acquire more information, please contact Lena Basile, Chief Executive Officer by calling (626) 844-3800 during business hours. You can also write to the business’ Single Location at 133 North Altadena Drive # 310, Pasadena, California CA 91107. You can also visit the company’s website at neumedicines.com. View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Neumedicines Inc |
| Representative: | Lena Basile, Chief Executive Officer |
| Place of Business: | 133 North Altadena Drive # 310, Pasadena, CA 91107 |
| Contact Number: | (626) 844-3800 |
| Website: | neumedicines.com |
| Type of Service: | Medical Research |
| SIC Number: | 8733 |
| NAICS Number: | 5417114 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 2002 |
| Income/Year: | Unknown |
| Laborers: | 1 to 4 |
| Share This Company: |
Neumedicines Inc is a company operating from Los Angeles, California providing professional Medical Research and relevant B2B variables. It was founded in 2002 and registered with the SIC code 8733 as Medical Research, and with the NAICS code 5417114 as Medical Research.
With a current employee count of 1 to 4, Neumedicines Inc has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Lena Basile, Chief Executive Officer at (626) 844-3800 for related queries, or to locate its Single Location using the coordinates 34.14844,-118.09868.
The Single Location can also be found at the street address 133 North Altadena Drive # 310 in Pasadena, California 91107 and can be engaged online through the company website at neumedicines.com, the company Twitter , and Facebook page .